Nutrien (0NHS) Share Forecast & Price Target
0NHS Analyst Ratings
Moderate Buy
9Buy6Hold2Sell
Based on 17 analysts giving stock ratings to Nutrien in the past 3 months
0NHS Stock 12 Month Forecast
Average Price Target
$76.13▲(9.80% Upside)Based on 17 Wall Street analysts offering 12 month price targets for Nutrien in the last 3 months. The average price target is $76.13 with a high forecast of $85.00 and a low forecast of $62.00. The average price target represents a 9.80% change from the last price of $69.34.
Past 12 Months12 Month ForecastDec2025Sep2026
High$85.00
Average$76.13
Low$62.00
Highest Price TargetHighest$85.00Average Price Target$76.13Lowest Price TargetLowest$62.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Lucas Beaumont | UBS | $59→$62 | sell | -10.59%Downside | Assigned | 10/27/26 | ||
| Vitaly Kononov | Freedom Capital Markets | $78 | hold | 12.49%Upside | Initiated | 10/27/26 | ||
| Kristen Owen | Oppenheimer | $80→$78 | buy | 12.49%Upside | Reiterated | 10/22/26 | ||
| Matthew DeYoe | Bank of America Securities | $76→$80 | buy | 15.37%Upside | Reiterated | 10/19/26 | ||
| Benjamin Theurer | Barclays | $78 | buy | 12.49%Upside | Reiterated | 10/16/26 | ||
| Andrew Wong CFA | RBC Capital | $85 | buy | 22.58%Upside | Reiterated | 10/13/26 | ||
| Laurence Alexander | Jefferies | $63→$71 | hold | 2.39%Upside | Reiterated | 10/12/26 | ||
| Vincent Andrews | Morgan Stanley | $76 | buy | 9.60%Upside | Assigned | 10/07/26 | ||
| Joel Jackson | BMO Capital | $82 | buy | 18.26%Upside | Assigned | 10/06/26 | ||
| Mazahir Mammadli | Rothschild & Co Redburn | $65→$64 | hold | -7.70%Downside | Reiterated | 09/28/26 | ||
| Salvator Tiano | KeyBanc | ― | hold | ― | Initiated | 09/11/26 | ||
| Ahmed Abdullah | National Bank | $74→$77 | hold | 11.05%Upside | Downgraded | 08/24/26 | ||
| Michael Tupholme | TD Cowen | $83 | buy | 19.70%Upside | Reiterated | 08/11/26 | ||
| Hamir Patel | CIBC | $85→$84 | buy | 21.14%Upside | Reiterated | 08/10/26 | ||
| Jeffrey Zekauskas | J.P. Morgan | $80→$75 | buy | 8.16%Upside | Reiterated | 08/07/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Lucas Beaumont | 10/27/26 | $59→$62 | sell | -10.59%Downside | Assigned | UBS | ||
| Vitaly Kononov | 10/27/26 | $78 | hold | 12.49%Upside | Initiated | Freedom Capital Markets | ||
| Kristen Owen | 10/22/26 | $80→$78 | buy | 12.49%Upside | Reiterated | Oppenheimer | ||
| Matthew DeYoe | 10/19/26 | $76→$80 | buy | 15.37%Upside | Reiterated | Bank of America Securities | ||
| Benjamin Theurer | 10/16/26 | $78 | buy | 12.49%Upside | Reiterated | Barclays | ||
| Andrew Wong CFA | 10/13/26 | $85 | buy | 22.58%Upside | Reiterated | RBC Capital | ||
| Laurence Alexander | 10/12/26 | $63→$71 | hold | 2.39%Upside | Reiterated | Jefferies | ||
| Vincent Andrews | 10/07/26 | $76 | buy | 9.60%Upside | Assigned | Morgan Stanley | ||
| Joel Jackson | 10/06/26 | $82 | buy | 18.26%Upside | Assigned | BMO Capital | ||
| Mazahir Mammadli | 09/28/26 | $65→$64 | hold | -7.70%Downside | Reiterated | Rothschild & Co Redburn | ||
| Salvator Tiano | 09/11/26 | ― | hold | ― | Initiated | KeyBanc | ||
| Ahmed Abdullah | 08/24/26 | $74→$77 | hold | 11.05%Upside | Downgraded | National Bank | ||
| Michael Tupholme | 08/11/26 | $83 | buy | 19.70%Upside | Reiterated | TD Cowen | ||
| Hamir Patel | 08/10/26 | $85→$84 | buy | 21.14%Upside | Reiterated | CIBC | ||
| Jeffrey Zekauskas | 08/07/26 | $80→$75 | buy | 8.16%Upside | Reiterated | J.P. Morgan |
Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector
Best Analysts Covering Nutrien
3 Months
Success Rate12/16 ratings generated profit
75%
Average Return
+9.09%
Copying Steve Hansen's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +9.09% per trade.
1 Year
Success Rate13/18 ratings generated profit
72%
Average Return
+11.78%
Copying Michael Tupholme's trades and holding each position for 1 Year would result in 72.22% of your transactions generating a profit, with an average return of +11.78% per trade.
2 Years
Success Rate15/20 ratings generated profit
75%
Average Return
+6.42%
Copying Ben Isaacson's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +6.42% per trade.
0NHS Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 21 | 21 | 19 | 19 | 18 |
| Hold | 8 | 6 | 6 | 6 | 6 |
| Sell | 3 | 3 | 2 | 2 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 32 | 30 | 27 | 27 | 27 |
In the current month, 0NHS has received 18 Buy Ratings, 6 Hold Ratings, and 3 Sell Ratings. 0NHS average Analyst price target in the past 3 months is 76.13.
0NHS Financial Forecast
High$1.16
Consensus$0.81
Low$0.60
0NHS Earnings Forecast
Next quarter’s earnings estimate for 0NHS is $0.81 with a range of $0.60 to $1.16. The previous quarter’s EPS was $2.62. Its overall industry beat the EPS estimate 45.00% of the time in the past 12 months.
High$6.07B
Consensus$5.78B
Low$5.5B
0NHS Sales Forecast
Next quarter’s sales forecast for 0NHS is $5.78B with a range of $5.50B to $6.07B. The previous quarter’s sales results were $10.71B. Its overall industry beat sales estimates 58.40% of the time in the past 12 months.
0NHS Stock Forecast FAQ
What is GB:0NHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Nutrien’s 12-month average price target is $76.13.
What is GB:0NHS’s upside potential, based on the analysts’ average price target?
Nutrien has 9.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Nutrien a Buy, Sell or Hold?
Nutrien has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 6 hold ratings and 2 sell ratings.
What is Nutrien’s share price target?
The average share price target for Nutrien is $76.13. This is based on 17 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $85.00, and the lowest forecast is $62.00. The average share price target represents a 9.80% increase from the current price of $69.34.
What do analysts say about Nutrien?
Nutrien’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Street analysts.
How can I buy shares of Nutrien?
To buy shares of GB:0NHS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.